EquityFlowCompanies › Samphire Neuroscience

Samphire Neuroscience

healthtech · GB

Medtech startup with a neurotechnology wearable (Nettle) offering a drug-free solution for PMS and menstrual pain.

Funding history

DateRoundAmount
Feb 2024Pre Seed
Samphire Neuroscience secured $2.3M in pre-seed funding from SOSV and others to launch its Nettle neurostimulation wearable for PMS and period pain.
$2.3M

Investors

AfterworkFirstpickSOSV

Similar companies in healthtech

Explore funding flow on EquityFlow →